Transcriptional activation: risky business

被引:87
作者
Tansey, WP [1 ]
机构
[1] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
关键词
D O I
10.1101/gad.896501
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transcriptional regulation is all about getting RNA polymerase to the right place on the gene at the right time and making sure that it is competent to conduct transcription. Traditional views of this process place most of their emphasis on the events that precede initiation of transcription. We imagine a promoter-bound transcriptional activator (or collection of activators) recruiting components of the basal transcriptional machinery to the DNA, eventually leading to the recruitment of RNA polymerase II and the onset of gene transcription. Although these events play a crucial role in regulating gene expression, they are only half the story. Correct regulation of transcription requires that polymerase not only initiates when and where it should, but that it stops initiating when no longer appropriate. But how are the signals from transcriptional activators, telling RNA polymerase to fire, terminated! Is this process governed by chance, with activators simply falling off the promoter at a certain frequency? Or is there some more direct mechanism, whereby activators are aggressively limited from uncontrolled promoter activation? A new article by Chi et al. (2001) suggests the latter may be true, and provides a mechanism for how a component of the basal transcription machinery can mark the activators it has encountered, sentencing them to an early death or banishing them from the nucleus. The ability of the basal transcriptional apparatus to mark activators provides an efficient way to limit activator function and ensures that continuing transcription initiation at a promoter is coupled to the continuing synthesis and activation of transcriptional activators.
引用
收藏
页码:1045 / 1050
页数:6
相关论文
共 39 条
[1]   Monitoring the GCN4 protein-mediated response in the yeast Saccharomyces cerevisiae [J].
Albrecht, G ;
Mösch, HU ;
Hoffmann, B ;
Reusser, U ;
Braus, GH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :12696-12702
[2]   Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase [J].
Chi, Y ;
Huddleston, MJ ;
Zhang, XL ;
Young, RA ;
Annan, RS ;
Carr, SA ;
Deshaies, RJ .
GENES & DEVELOPMENT, 2001, 15 (09) :1078-1092
[3]   ACCUMULATION OF P53 IN A MUTANT-CELL LINE DEFECTIVE IN THE UBIQUITIN PATHWAY [J].
CHOWDARY, DR ;
DERMODY, JJ ;
JHA, KK ;
OZER, HL .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) :1997-2003
[4]   TAF(11)250 is a bipartite protein kinase that phosphorylates the basal transcription factor RAP74 [J].
Dikstein, R ;
Ruppert, S ;
Tjian, R .
CELL, 1996, 84 (05) :781-790
[5]   The Gcn4p activation domain interacts specifically in vitro with RNA polymerase II holoenzyme, TFIID, and the Adap-Gcn5p coactivator complex [J].
Drysdale, CM ;
Jackson, BM ;
McVeigh, R ;
Klebanow, ER ;
Bai, Y ;
Kokubo, T ;
Swanson, M ;
Nakatani, Y ;
Weil, PA ;
Hinnebusch, AG .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (03) :1711-1724
[6]   A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p [J].
Feldman, RMR ;
Correll, CC ;
Kaplan, KB ;
Deshaies, RJ .
CELL, 1997, 91 (02) :221-230
[7]   NEGATIVE EFFECT OF THE TRANSCRIPTIONAL ACTIVATOR GAL4 [J].
GILL, G ;
PTASHNE, M .
NATURE, 1988, 334 (6184) :721-724
[8]   Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway [J].
Gross-Mesilaty, S ;
Reinstein, E ;
Bercovich, B ;
Tobias, KE ;
Schwartz, AL ;
Kahana, C ;
Ciechanover, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8058-8063
[9]   Degradation of E2F by the ubiquitin-proteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming proteins [J].
Hateboer, G ;
Kerkhoven, RM ;
Shvarts, A ;
Bernards, R ;
Beijersbergen, RL .
GENES & DEVELOPMENT, 1996, 10 (23) :2960-2970
[10]   Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast [J].
Henchoz, S ;
Chi, Y ;
Catarin, B ;
Herskowitz, I ;
Deshaies, RJ ;
Peter, M .
GENES & DEVELOPMENT, 1997, 11 (22) :3046-3060